Request a free sample copy in PDF or view the report [email protected] https://www.expertmarketresearch.com/reports/biologics-market/requestsample
The key highlights of the report include:
Market Overview (2017-2027)
- Forecast CAGR (2022-2027): 4.1%
Geographically, North America occupies a significant share in the market growth of biologics. This is supported by the presence of several leading companies and the subsequent rising investments in the R&D sector. Meanwhile, the Asia Pacific region is expected to make significant contributions to the market in the coming years owing to the developing healthcare sector in the region. Further, the market is anticipated to be driven by the dominance of microbial sources as a major portion of the product range has its source in the microbial expressions system, which are used during the treatment of several chronic diseases depending upon the type of monoclonal antibodies. The market is being further driven by the products used in cancer treatment applications.
Industry Definition and Segmentation
Biologics are defined as disease-modifying antirheumatic drugs (DMARDs). Also known as biological drugs, these are made from living organisms or consist of their components, such as blood, cells, genes, tissues, allergens, and recombinant proteins. These drugs control the production of vital proteins, and aid in the modification of human hormones and cells while producing substances to activate and suppress the immune system.
Explore the full report with the table of [email protected] https://www.expertmarketresearch.com/reports/biologics-market
On the basis of source, the market can be divided into:
- Microbial Source
- Mammalian Source
Based on product type, the market can be classified into:
- Monoclonal Antibodies
- Murine MABs
- Chimeric MABs
- Humanised MABs
- Human MABs
- Recombinant Proteins
- Antisense, RNAi and Molecular Therapy
The market, based on manufacturing, can be distinguished into:
On the basis of disease category, the market is segmented into:
- Infectious Disease
- Immunological Disorders
- Cardiovascular disorders
- Haematologic Disorders
The regional markets for biologics include:
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
The growth in the global market for biologics is being driven by the exceeding cases of chronic disorders. As a result, the increase in demand for efficient diagnostics and treatment drugs is pushing the market growth of biologics. Further, the year-by-year increase in cancer patients is propelling the need to modify therapies and introduce drugs that can enhance the immune system and destroy cancer-causing cells at the earliest. This demand is likely to boost the market growth of biologics in the coming years. The growing research and development (R&D) activities by prominent market leaders are backed up by government initiatives and investments.
Key Market Players
The major players in the market are Samsung Biologics, Amgen Inc., Novo Nordisk A/S, Pfizer Inc., Merck & Co., Inc., Precision Biologics, Inc., and F. Hoffmann-La Roche AG, among others. The report covers the market shares, capacities, plant turnarounds, expansions, investments and mergers and acquisitions, among other latest developments of these market players.
Expert Market Research is a leading business intelligence firm, providing custom and syndicated market reports along with consultancy services for our clients. We serve a wide client base ranging from Fortune 1000 companies to small and medium enterprises. Our reports cover over 100 industries across established and emerging markets researched by our skilled analysts who track the latest economic, demographic, trade and market data globally.
At Expert Market Research, we tailor our approach according to our clients’ needs and preferences, providing them with valuable, actionable and up-to-date insights into the market, thus, helping them realize their optimum growth potential. We offer market intelligence across a range of industry verticals which include Pharmaceuticals, Food and Beverage, Technology, Retail, Chemical and Materials, Energy and Mining, Packaging and Agriculture.
Company Name: EMR Inc.
Contact Person: Steven Luke, Corporate Sales Specialist – U.S.A.
Email: [email protected]
Toll Free Number: +1-415-325-5166 | +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Country: United States
Also, Check Procurement Intelligence which provides you with Infallible research solutions.
Read More Reports:
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.